Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004 Dec;114(12):2129-34

Date

11/27/2004

Pubmed ID

15564833

DOI

10.1097/01.mlg.0000149445.07146.03

Scopus ID

2-s2.0-10044275611   145 Citations

Abstract

OBJECTIVES/HYPOTHESIS: The objective was to investigate the potential use of pepsin and carbonic anhydrase isoenzyme III (CA-III) as diagnostic markers for laryngopharyngeal reflux disease.

STUDY DESIGN: Prospective cell biological investigation was conducted of laryngeal biopsy specimens taken from 9 patients with laryngopharyngeal reflux disease and 12 normal control subjects using antibodies specific for human pepsin (produced in the authors' laboratory within the Department of Otolaryngology at Wake Forest University Health Sciences, Winston-Salem, NC) and CA-III.

METHODS: Laryngeal biopsy specimens were frozen in liquid nitrogen for Western blot analysis and fixed in formalin for pepsin immunohistochemical study. Specimens between two groups (patients with laryngopharyngeal reflux disease and control subjects) were compared for the presence of pepsin. Further analyses investigated the correlation between pepsin, CA-III depletion, and pH testing data.

RESULTS: Analysis revealed that the level of pepsin was significantly different between the two groups (P < .001). Secondary analyses demonstrated that presence of pepsin correlated with CA-III depletion in the laryngeal vocal fold and ventricle (P < .001) and with pH testing data in individuals with laryngopharyngeal reflux disease.

CONCLUSION: Pepsin was detected in 8 of 9 patients with laryngopharyngeal reflux disease, but not in normal control subjects (0 of 12). The presence of pepsin was associated with CA-III depletion in the laryngeal vocal fold and ventricle. Given the correlation between laryngopharyngeal reflux disease and CA-III depletion, it is highly plausible that CA-III depletion, as a result of pepsin exposure during laryngopharyngeal reflux, predisposes laryngeal mucosa to reflux-related inflammatory damage.

Author List

Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J

Author

Nikki Johnston PhD Associate Professor in the Otolaryngology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Biomarkers
Biopsy, Needle
Blotting, Western
Carbonic Anhydrase III
Case-Control Studies
Chi-Square Distribution
Electrophoresis, Polyacrylamide Gel
Esophagitis, Peptic
Female
Gastric Acidity Determination
Gastroesophageal Reflux
Humans
Immunohistochemistry
Isoenzymes
Laryngeal Mucosa
Male
Pepsin A
Probability
Prognosis
Prospective Studies
Risk Assessment
Sampling Studies
Sensitivity and Specificity
Severity of Illness Index
Tissue Culture Techniques
jenkins-FCD Prod-480 9a4deaf152b0b06dd18151814fff2e18f6c05280